Cargando…

Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling

Detalles Bibliográficos
Autores principales: Meves, Alexander, Eggermont, Alexander M.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367022/
https://www.ncbi.nlm.nih.gov/pubmed/32838203
http://dx.doi.org/10.1016/j.mayocpiqo.2020.05.009
_version_ 1783560341233336320
author Meves, Alexander
Eggermont, Alexander M.M.
author_facet Meves, Alexander
Eggermont, Alexander M.M.
author_sort Meves, Alexander
collection PubMed
description
format Online
Article
Text
id pubmed-7367022
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73670222020-07-20 Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling Meves, Alexander Eggermont, Alexander M.M. Mayo Clin Proc Innov Qual Outcomes Letter to the Editor Elsevier 2020-07-17 /pmc/articles/PMC7367022/ /pubmed/32838203 http://dx.doi.org/10.1016/j.mayocpiqo.2020.05.009 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Meves, Alexander
Eggermont, Alexander M.M.
Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
title Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
title_full Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
title_fullStr Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
title_full_unstemmed Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
title_short Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
title_sort deselecting melanoma patients for sentinel lymph node biopsy during covid-19: clinical utility of tumor molecular profiling
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367022/
https://www.ncbi.nlm.nih.gov/pubmed/32838203
http://dx.doi.org/10.1016/j.mayocpiqo.2020.05.009
work_keys_str_mv AT mevesalexander deselectingmelanomapatientsforsentinellymphnodebiopsyduringcovid19clinicalutilityoftumormolecularprofiling
AT eggermontalexandermm deselectingmelanomapatientsforsentinellymphnodebiopsyduringcovid19clinicalutilityoftumormolecularprofiling